Improve Patient Comprehension, Engagement, and Retention with eConsent
Archive Version – this webinar was originally presented on June 15, 2017 Listen to the webinar recording using the link below.
Informed consent is an ethical, mandatory, and fundamental principle of healthcare research. It respects the clinical trial volunteer’s authority to decide whether to participate, reviews their role and responsibilities, and highlights the risks involved. Unfortunately, 18 to 30% of patients enrolling in a trial drop out, with 13% of drop-outs due to patient misunderstanding of consent expectations or related issues.
FDA guidance and patient advocacy groups are driving adoption of electronic consent (eConsent) to make the consenting process more engaging and easier to understand for patients and caregivers. With patient recruitment costs accounting for nearly 1/3 of the total trial cost, there is a financial as well as an ethical reason to make sure patients fully understand the clinical trial process and their vital role. This webinar will review the current informed consent process and how eConsent may help to improve patient comprehension, engagement, and retention.
The presenter from CISCRP will discuss:
● The purpose of informed consent
● Current rules and regulations around the informed consent process
● Data and insights on the number of patients who drop out of studies due to lack of understanding the informed consent
The presenter from DrugDev will discuss how eConsent:
● Ensures patient understanding through multimedia education
● Improves patient retention and reduces recruitment needs
● Provides insight and metrics into how patients read and understand documents
● Improves regulatory compliance
About the Speakers:
Ken Getz is the Founder and Board Chair at CISCRP, as well as an associate professor at the Center for the Study of Drug Development, Tufts University School of Medicine where he studies R&D management and operating models, investigative site, outsourcing, and study volunteer trends and policies. A well-known speaker at conferences, symposia, universities, and corporations, Ken has published more than 200 articles and chapters in peer-review journals, books, and in the trade press.
Eric Delente is the President of DrugDev Patient Solutions. Eric has more than 20 years of experience leading technical and creative teams in the design and implementation of numerous award-winning online science, healthcare and clinical research web applications. In 2003 he co-founded SecureConsent, and pioneered the definitive eConsent solution by working closely with patients, IRBs, CROs, sponsors, hospital systems, academic institutions and regulatory authorities. DrugDev acquired SecureConsent in 2016.